Skip to content

Schrodinger SDGR Additional Paid-In Capital

Additional Paid-In Capital at other companies

Absci Corporation logo
Absci CorporationABSI
$826.04M+12.4%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$196.62M+16.6%
Septerna, Inc. logo
Septerna, Inc.SEPN
$554.87M+2.8%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$1.57B+23.2%
Revvity logo
RevvityRVTY
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-41.8%
Enterprise value$984.71M-44.4%
P/S4.5×-4.0×

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's additional paid-in capital?
Schrodinger (SDGR) reported additional paid-in capital of $1B in Q1 2026.
How has Schrodinger's additional paid-in capital changed year-over-year?
Schrodinger's additional paid-in capital increased by 4.6% year-over-year, from $958.03M to $1B.
What is the long-term trend for Schrodinger's additional paid-in capital?
Over 5 years (2020 to 2025), Schrodinger's additional paid-in capital has grown at a 5.7% compound annual growth rate (CAGR), from $752.56M to $992.02M.
What does additional paid-in capital mean?
This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.